|
[1]
|
Pang, R.W., Joh, J.W., Johnson, P.J., Monden, M., Pawlik, T.M., et al. (2008) Biology of hepatocellular carcinoma. Annals of Surgical Oncology, 15, 962-971.
|
|
[2]
|
He, J., Gu, D., Wu, X., Reynolds, K., Duan, X., et al. (2005) Major causes of death among men and women in China. New England Journal of Medicine, 353, 1124-1134.
|
|
[3]
|
Oshlack, A., Robinson, M.D. and Young, M.D. (2010) From RNA-seq reads to differential expression results. Genome Biology, 11, 220.
|
|
[4]
|
Venook, A.P., Papandreou, C., Furuse, J. and de Guevara, L.L. (2010) The incidence and epidemiology of hepatocellular carcinoma: A global and regional perspective. Oncologist, 15, 5-13.
|
|
[5]
|
Sanyal, A.J., Yoon, S.K. and Lencioni, R. (2010) The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist, 15, 14-22.
|
|
[6]
|
Trevisani, F., Cantarini, M.C., Wands, J.R. and Bernardi, M. (2008) Recent advances in the natural history of hepatocellular carcinoma. Carcinogenesis, 29, 1299-1305.
|
|
[7]
|
Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., et al. (2013) Signatures of mutational pro- cesses in human cancer. Nature, 500, 415-421.
|
|
[8]
|
Hoadley, K.A., Yau, C., Wolf, D.M., Cherniack, A.D., Tamborero, D., et al. (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell, 158, 929-944.
|
|
[9]
|
Barrio-Real, L., Benedetti, L.G., Engel, N., Tu, Y., Cho, S., et al. (2014) Subtype-specific overexpression of the Rac- GEF P-REX1 in breast cancer is associated with promoter hypomethylation. Breast Cancer Research, 16, 441.
|
|
[10]
|
Yang, D., Sun, Y., Hu, L., Zheng, H., Ji, P., et al. (2013) Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell, 23, 186-199.
|
|
[11]
|
Brennan, C.W., Verhaak, R.G., McKenna, A., Campos, B., Noushmehr, H., et al. (2013) The somatic genomic landscape of glioblastoma. Cell, 155, 462-477.
|